[Federal Register Volume 78, Number 223 (Tuesday, November 19, 2013)]
[Notices]
[Pages 69417-69418]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-27653]



[[Page 69417]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60 Day-14-14CL]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call 404-639-7570 or 
send comments to LeRoy Richardson, 1600 Clifton Road, MS-D74, Atlanta, 
GA 30333 or send an email to [email protected].
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Written comments should be received 
within 60 days of this notice.

Proposed Project

    An Investigation of Lung Health at an Indium-Tin Oxide Production 
Facility--New--National Institute for Occupational Safety and Health 
(NIOSH), Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    The mission of the National Institute for Occupational Safety and 
Health (NIOSH) is to promote safety and health at work for all people 
through research and prevention. The Occupational Safety and Health 
Act, Public Law 91-596 (section 20[a] [1]), authorizes NIOSH to conduct 
research to advance the health and safety of workers. NIOSH is 
proposing to conduct a study regarding the lung health of workers at an 
indium-tin oxide production facility.
    Indium-tin oxide (ITO) is a sintered material used in the 
manufacture of devices such as liquid crystal displays, touch panels, 
solar cells, and architectural glass. Indium lung disease is a novel, 
potentially fatal industrial disease that has occurred in workers 
making, using, or recycling ITO. This project aims to understand and 
prevent this occupational lung disease by investigating the 
relationship between exposure and lung health among current ITO 
manufacturing workers.
    CDC requests Office of Management and Budget (OMB) approval to 
collect standardized information from current employees of the ITO 
production facility through an informed consent document, an 
interviewer-administered questionnaire, and a contact information form. 
As part of the same project, employees will be offered the opportunity 
to participate in medical testing and personal air sampling.
    The questionnaire will collect contact information, demographic 
information, respiratory symptoms and diagnoses, work history, and 
cigarette smoking history. The questionnaire will allow NIOSH to report 
individual medical test results to each participant and to analyze 
aggregate data from the workforce to determine risk factors for 
abnormal lung health indices derived from the medical test results. The 
individual results will be used by employees and their personal 
physicians to make medical decisions, such as whether to pursue 
additional testing. The aggregate results will be used by NIOSH, 
facility management, and employees in ongoing efforts to reduce 
exposures and monitor key health indices.
    For this study, we will recruit all current employees of the ITO 
production facility. Participation is voluntary. Employees who wish to 
participate in the questionnaire and medical testing will review and 
sign an informed consent document. Employees who wish to participate in 
the personal air sampling and would like to receive personal results 
will complete a contact information form. We anticipate approximately 
100 study participants. The questionnaire will be administered 
privately at the workplace during normal working hours by trained NIOSH 
staff. Employees who are not available at the workplace during the 
study will be offered the opportunity to respond to the questionnaire 
at a later date by telephone. There are no costs to participants other 
than their time.
    The total estimated burden for the one-time collection of data is 
66 hours.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                     Number of       Number of      burden per     Total burden
      Type of respondents           Form name       respondents    responses per   response  (in    (in hours)
                                                                    respondent        hours)
----------------------------------------------------------------------------------------------------------------
Current ITO production          Informed consent             100               1           15/60              25
 facility employees.             document.
                                Questionnaire...             100               1           20/60              33
                                Contact                      100               1            5/60               8
                                 information
                                 form.
                               ---------------------------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............              66
----------------------------------------------------------------------------------------------------------------



[[Page 69418]]

LeRoy Richardson,
Chief, Office of Scientific Integrity, Office of the Associate Director 
for Science, Office of the Director, Centers for Disease Control and 
Prevention.
[FR Doc. 2013-27653 Filed 11-18-13; 8:45 am]
BILLING CODE 4163-18-P